Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Elder

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 23, 2015
Analytical advances in pharmaceutical impurity profilingRené Holm, David P Elder
The Journal of Pharmacy and Pharmacology|February 19, 2009
Drug substances presented as sulfonic acid salts: overview of utility, safety and regulationDavid P Elder, David J Snodin
Regulatory Toxicology and Pharmacology : RTP|January 11, 2019
Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan productsDavid J Snodin, David P Elder
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2015
Methodology of oral formulation selection in the pharmaceutical industryMartin Kuentz, René Holm, David P Elder
Journal of Pharmaceutical Sciences|July 12, 2016
Antibiotic Resistance: The Need For a Global StrategyDavid P Elder, Martin Kuentz, René Holm
Journal of Pharmaceutical Sciences|January 3, 2017
Medicines for Pediatric Patients-Biopharmaceutical, Developmental, and Regulatory ConsiderationsDavid P Elder, René Holm, Martin Kuentz
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 25, 2015
Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerationsDavid P Elder, Martin Kuentz, René Holm
The Journal of Pharmacy and Pharmacology|August 16, 2014
The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug productDavid P Elder, James E Patterson, René Holm
Journal of Pharmaceutical Sciences|March 11, 2021
Tolerability of risk: A commentary on the nitrosamine contamination issueDavid P Elder, George E Johnson, David J Snodin
International Journal of Pharmaceutics|November 28, 2012
Use of pharmaceutical salts and cocrystals to address the issue of poor solubilityDavid P Elder, René Holm, Heidi Lopez de Diego
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 23, 2015
Analytical advances in pharmaceutical impurity profilingRené Holm, David P Elder
The Journal of Pharmacy and Pharmacology|February 19, 2009
Drug substances presented as sulfonic acid salts: overview of utility, safety and regulationDavid P Elder, David J Snodin
Regulatory Toxicology and Pharmacology : RTP|January 11, 2019
Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan productsDavid J Snodin, David P Elder
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2015
Methodology of oral formulation selection in the pharmaceutical industryMartin Kuentz, René Holm, David P Elder
Journal of Pharmaceutical Sciences|July 12, 2016
Antibiotic Resistance: The Need For a Global StrategyDavid P Elder, Martin Kuentz, René Holm
Journal of Pharmaceutical Sciences|January 3, 2017
Medicines for Pediatric Patients-Biopharmaceutical, Developmental, and Regulatory ConsiderationsDavid P Elder, René Holm, Martin Kuentz
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 25, 2015
Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerationsDavid P Elder, Martin Kuentz, René Holm
The Journal of Pharmacy and Pharmacology|August 16, 2014
The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug productDavid P Elder, James E Patterson, René Holm
Journal of Pharmaceutical Sciences|March 11, 2021
Tolerability of risk: A commentary on the nitrosamine contamination issueDavid P Elder, George E Johnson, David J Snodin
International Journal of Pharmaceutics|November 28, 2012
Use of pharmaceutical salts and cocrystals to address the issue of poor solubilityDavid P Elder, René Holm, Heidi Lopez de Diego
Pageof 2